A Phase 2 study of HS-10353 in postpartum depression

Not Yet Recruiting Phase 2 NCT05937867

Study Description

Investigating a new medication for treating postpartum depression

Study Details

Registry ID:
NCT05937867
Conditions:
Postpartum Depression
Phase:
Phase 2
Target Enrollment:
96 participants
Start Date:
Age Range:
18–45 years
Gender:
Female
Healthy Volunteers:
No

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →